Effect of the Family-Centered Advance Care Planning for Teens with Cancer Intervention on Sustainability of Congruence About End-of-Life Treatment Preferences: A Randomized Clinical Trial
- PMID: 35819787
- PMCID: PMC9277499
- DOI: 10.1001/jamanetworkopen.2022.20696
Effect of the Family-Centered Advance Care Planning for Teens with Cancer Intervention on Sustainability of Congruence About End-of-Life Treatment Preferences: A Randomized Clinical Trial
Abstract
Importance: The effect of pediatric advance care planning (pACP) on the sustainability of end-of-life treatment preference congruence between adolescents with cancer and their families has not been examined.
Objective: To evaluate the longitudinal efficacy of the Family-Centered Advance Care Planning for Teens with Cancer (FACE-TC) intervention to sustain adolescent-family congruence about end-of-life treatment preferences.
Design, setting, and participants: This multisite, assessor-blinded, randomized clinical trial enrolled adolescents with cancer (aged 14-21 years) and their family members from 4 pediatric hospitals between July 16, 2016, and April 30, 2019. Participants were randomized 2:1 to FACE-TC (intervention group) or treatment as usual (control group) and underwent 5 follow-up visits over an 18-month postintervention period. Intention-to-treat analyses were conducted from March 9, 2021, to April 14, 2022.
Exposures: Adolescent-family dyads randomized to the FACE-TC group received 3 weekly 60-minute sessions consisting of the discussion and/or completion of the Lyon Family-Centered Advance Care Planning Survey (session 1), Respecting Choices Next Steps pACP conversation (session 2), and Five Wishes advance directive (session 3). Dyads in the control group received treatment as usual. Both groups received pACP information.
Main outcomes and measures: Congruence was measured by completion of the Statement of Treatment Preferences (a document that discusses 4 hypothetical clinical situations and treatment choices for each scenario: continue all treatments, stop all efforts to keep me alive, or unsure) after session 2 (time 1) and at 3 months (time 2), 6 months (time 3), 12 months (time 4), and 18 months (time 5) after intervention. The influence of FACE-TC on the trajectory of congruence over time was measured by longitudinal latent class analysis.
Results: A total of 252 participants (126 adolescent-family dyads) were randomized. Adolescents (mean [SD] age, 17 [1.9] years) and family members (mean [SD] age, 46 [8.3] years) were predominantly female (72 [57%] and 104 [83%]) and White individuals (100 [79%] and 103 [82%]). There was an 83% (104 of 126) retention at the 18-month assessment. Two latent classes of congruence over time were identified: high-congruence latent class (69 of 116 [60%]) and low-congruence latent class (47 of 116 [41%]). The dyads in the FACE-TC group had a 3-fold odds of being in the high-congruence latent class (odds ratio [OR], 3.22; 95% CI, 1.09-9.57) compared with the control group. Statistically significant differences existed at 12 months (β [SE] = 1.17 [0.55]; P = .03]) but not at 18 months (OR, 2.08; 95% CI, 0.92-4.69). In the high-congruence latent class, good agreement (agreement on 2 or 3 of 4 situations) increased over 12 months. White adolescents and families had significantly greater odds of congruence than a small population of American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, or multiracial adolescents and families (OR, 3.97; 95% CI, 1.07-14.69).
Conclusions and relevance: Results of this trial showed that, for those who received the FACE-TC intervention, the families' knowledge of their adolescents' end-of-life treatment preferences was sustained for 1 year, suggesting yearly follow-up sessions. Race and ethnicity-based differences in the sustainability of this knowledge reflect a difference in the effect of the intervention and require further study.
Trial registration: ClinicalTrials.gov Identifier: NCT02693665.
Conflict of interest statement
Figures


Similar articles
-
An Intervention in Congruence for End-of-Life Treatment Preference: A Randomized Trial.Pediatrics. 2022 May 1;149(5):e2021054796. doi: 10.1542/peds.2021-054796. Pediatrics. 2022. PMID: 35425986 Free PMC article. Clinical Trial.
-
A randomized clinical trial of adolescents with HIV/AIDS: pediatric advance care planning.AIDS Care. 2017 Oct;29(10):1287-1296. doi: 10.1080/09540121.2017.1308463. Epub 2017 Mar 30. AIDS Care. 2017. PMID: 28359212 Free PMC article. Clinical Trial.
-
Congruence Gaps Between Adolescents With Cancer and Their Families Regarding Values, Goals, and Beliefs About End-of-Life Care.JAMA Netw Open. 2020 May 1;3(5):e205424. doi: 10.1001/jamanetworkopen.2020.5424. JAMA Netw Open. 2020. PMID: 32427325 Free PMC article.
-
Advance care planning for adults with heart failure.Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD013022. doi: 10.1002/14651858.CD013022.pub2. Cochrane Database Syst Rev. 2020. PMID: 32104908 Free PMC article.
-
Tailoring Resources to Help Children and Parents Manage Type 1 Diabetes [Internet].Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2019 Aug. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2019 Aug. PMID: 36701500 Free Books & Documents. Review.
Cited by
-
A Pilot Randomized Trial of an Advance Care Planning Video Decision Support Tool for Adolescents and Young Adults With Advanced Cancer.J Natl Compr Canc Netw. 2023 Jul;21(7):715-723.e17. doi: 10.6004/jnccn.2023.7021. J Natl Compr Canc Netw. 2023. PMID: 37433434 Free PMC article. Clinical Trial.
-
Advancing Advance Care Planning: Evaluating a Revised Version of Voicing My CHOiCES.J Palliat Med. 2025 Jan;28(1):92-96. doi: 10.1089/jpm.2024.0177. Epub 2024 Dec 5. J Palliat Med. 2025. PMID: 39636671
-
Advance Care Planning Conversations in Pediatric Patients with Refractory Oncologic Disease.Children (Basel). 2025 Apr 8;12(4):479. doi: 10.3390/children12040479. Children (Basel). 2025. PMID: 40310160 Free PMC article. Review.
-
Feasibility of a Serious Illness Communication Program for Pediatric Advance Care Planning.JAMA Netw Open. 2024 Jul 1;7(7):e2424626. doi: 10.1001/jamanetworkopen.2024.24626. JAMA Netw Open. 2024. PMID: 39058485 Free PMC article.
-
Advance Care Planning for Children With Rare Diseases: A Pilot RCT.Pediatrics. 2024 Jun 1;153(6):e2023064557. doi: 10.1542/peds.2023-064557. Pediatrics. 2024. PMID: 38699801 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous